Tacrolimus is an alternative therapy option for the treatment of adult steroid-resistant nephrotic syndrome: a prospective, multicenter clinical trial
International Urology and Nephrology, 06/12/2012
Fan L et al. – In conjunction with prednisone, tacrolimus (TAC) may be an alternative therapeutic regimen for adult steroid–resistant nephrotic syndrome (SRNS) patients. However, adverse events in these patients should be carefully monitored, especially at the beginning of treatment.